Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




International Symposium Aims to Improve Lab Medicine

By HospiMedica staff writers
Posted on 13 Sep 2006
A clinical laboratory education and accreditation organization called COLA (Columbia, MD, USA) convened its first International Symposium (Baltimore, MD, USA) from July 30-August 1, 2006, to discuss the role of laboratory medicine in relation to public-health needs and crises. More...
The two-day symposium dealt with the future of quality in medical laboratory testing.

Participants in the symposium included public health leaders from the Centers for Disease Control and Prevention (CDC, Atlanta, Georgia, USA), the U.S. Department of Health and Human Services (Washington, DC, USA), the World Medical Association (Ferney-Voltaire, France), the World Health Organization (WHO, Geneva, Switzerland), and other government and industry leaders from countries around the world.

"We need to understand where we are in the world as a first step, and to find out some of the common threads--issues we all share--around the world,” said Doug Beigel, CEO of COLA. "My insight is that leaders will emerge from different parts of the world to bring about quality in laboratory medicine.”

The group acknowledged that medical laboratories are the critical front line in diagnosis and treatment of diseases. A few major underlying themes of the meeting were lab quality and standards, the need to focus on the healthcare system in its entirety as opposed to specific diseases, and specific needs of labs around the world. Some of the specific topics discussed were the relevance of laboratory standards and training needs to laboratory personnel and the region; the misplaced focus on programs and funding for diseases rather than for entire healthcare systems; the lack of patient-centered standards and systems; the need for integration of the entire healthcare system; and the increasing role of governments in ensuring laboratory quality and information.



Related Links:
COLA

Gold Member
Fibrinolysis Assay
HemosIL Fibrinolysis Assay Panel
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Silver Member
PCR Plates
Diamond Shell PCR Plates
Alcohol Testing Device
Dräger Alcotest 7000
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.